Subscribe
The managers behind this company are looking to double shareholder returns within three to five years
The company is ahead of most rivals when it comes to margins and is planning smart acquisitions to entice shareholders
We published 100 ÉîÒ¹Ó°Ôº of the Week last year – with some more than doubling in value
There’s no better way to diversify your income than with a discounted and reliable dividend payer
This Danish drug giant has suffered plenty of misfortune, but better times lie ahead
The managers strike the right balance between high payouts and making sure your capital grows too
Rate cuts and deregulation could bolster this bank that’s already punching above its weight
The company isn’t merely recovering – the main division is now worth more than the group itself
There are plenty of execution risks in its grand transformation plan
A couple of pivotal years should see the Swiss giant through its patent erosion